Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosamax for ADT-induced bone loss in prostate cancer
NCT00236002Phase 3Terminated
- Sponsor
- Canadian Urology Research Consortium
- Start
- Jul 2005
- Primary completion
- Nov 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of alendronate in osteoporosis, sponsored by Canadian Urology Research Consortium. Started Jul 2005; status: terminated.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00236002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236002.